Retraction
MCM3AP-AS1/miR-876-5p/WNT5A axis regulates the proliferation of prostate cancer
Paper Information
Record ID:
53802
Author(s):
Journal:
Publication Date:
July 13, 2020
Retraction Date:
May 29, 2024
(1.5 year years ago)
Subjects:
Institutions:
Country:
šØš³ ChinaArticle Type:
Publisher:
Springer - Biomed Central (BMC)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (13)
13
Total Citations0
Post-Retraction13
Pre-Retraction0
Same DayImportance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer
Mohammad Taheri, Elham Badrlou, Bashdar Mahmud Hussen et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Mar 2023
17 citations
17 citations
435 days before retraction
The role of LncRNA MCM3AP-AS1 in human cancer
Shirin Azizidoost, Farhoodeh Ghaedrahmati, Mohadeseh Sheykhi-Sabzehpoush et al. (11 authors)
Clinical & Translational Oncology
Published: Aug 2022
9 citations
9 citations
644 days before retraction
The Role of Long Non-Coding RNAs in Epithelial-Mesenchymal Transition-Related Signaling Pathways in Prostate Cancer
Dexin Shen, Hongwei Peng, Caixia Xia et al. (7 authors)
Frontiers in Molecular Biosciences
Open Access
Published: Jul 2022
4 citations
4 citations
681 days before retraction
A novel inflammationāassociated prognostic signature for clear cell renal cell carcinoma
Gangcheng Liu, Donglan Xiong, Zhifei Che et al. (5 authors)
Oncology Letters
Open Access
Published: Jul 2022
16 citations
16 citations
687 days before retraction
A review on the role of MCM3AP-AS1 in the carcinogenesis and tumor progression
Soudeh GhafouriāFard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen et al. (5 authors)
Cancer Cell International
Open Access
Published: Jul 2022
12 citations
12 citations
694 days before retraction
Long Non-Coding RNA MCM3AP-AS1: A Crucial Role in Human Malignancies
Tao Ma, Fahong Wu, Hongxia Wu et al. (5 authors)
Pathology & Oncology Research
Open Access
Published: Jun 2022
3 citations
3 citations
713 days before retraction
MCM3AP-AS1: A LncRNA Participating in the Tumorigenesis of Cancer Through Multiple Pathways
Chengfu Yuan, Bei Wang, Jinlan Chen et al. (6 authors)
Mini-Reviews in Medicinal Chemistry
Published: Feb 2022
3 citations
3 citations
835 days before retraction
LncRNA MCM3AP-AS1 serves as a competing endogenous RNA of miR-218 to upregulate GLUT1 in papillary thyroid carcinoma
Rui Nian, Wanjun Li, Xiang Li et al. (8 authors)
Archives of Endocrinology and Metabolism
Open Access
Published: Jan 2022
4 citations
4 citations
879 days before retraction
Overexpression of circCDR1as drives oral squamous cell carcinoma progression
Lingling Cui, Chao Huang, Zhou Dun
Oral Diseases
Published: Nov 2021
14 citations
14 citations
916 days before retraction
Integrating analysis of circular RNA and mRNA expression profiles in doxorubicin induced cardiotoxicity mice
Xiaoqing Xing, Zhenzhen Tan, Xuran Zhi et al. (10 authors)
Journal of Applied Toxicology
Published: Oct 2021
9 citations
9 citations
947 days before retraction
MCM3AP-AS1: An Indispensable Cancer-Related LncRNA
Xiao Yu, Qingyuan Zheng, Qiyao Zhang et al. (6 authors)
Frontiers in Cell and Developmental Biology
Open Access
Published: Oct 2021
12 citations
12 citations
965 days before retraction
CircVAPA exerts oncogenic property in nonāsmall cell lung cancer by the miRā876ā5p/WNT5A axis
Yan Zhao, Qiangsheng Dai, Xiaohong Fu et al. (7 authors)
The Journal of Gene Medicine
Published: Feb 2021
16 citations
16 citations
1191 days before retraction
Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer
Yan-Fang Chen, Zheng Chen, Jian Mo et al. (8 authors)
Technology in Cancer Research & Treatment
Open Access
Published: Jan 2021
26 citations
26 citations
1244 days before retraction
Quick Stats
Total Citations:
13
Years Since Retraction:
1.5 year
Open Access:
Yes
Last Checked:
Jul 24, 2025